Crossmark

Prescription and self-reported use of endocrine therapy among Black hormone receptor-positive breast cancer survivors in the Detroit Research on Cancer Survivors cohort

Crossref DOI link: https://doi.org/10.1007/s10549-025-07816-1

Published Online: 2025-09-09

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fielder, Abigail M.

Kim, Seongho

Ruterbusch, Julie J.

Martin, Cydnie

Gottschlich, Anna

Schwartz, Ann G.

Beebe-Dimmer, Jennifer L.

Assad, Hadeel

Hamel, Lauren

Purrington, Kristen S.
Funding

Funding for this research was provided by:

Howard Hughes Medical Institute Gilliam Fellowship

American Cancer Society (ACS RSG-22-109-01-CTPS)

National Cancer Institute of the National Institutes of Health (U01 CA199240)

Karmanos Cancer Institute at Wayne State University (P30CA022453)
License Information

Text and Data Mining valid from 2025-09-09

Version of Record valid from 2025-09-09
More Information

Article History

Received: 7 May 2025

Accepted: 23 August 2025

First Online: 9 September 2025

Declarations

:

: The authors have not disclosed any competing interests.

Document is current

Any future updates will be listed below